Allogene Therapeutics, Inc. (ALLO) vs Tactile Systems Technology, Inc. (TCMD)
A side-by-side comparison of Allogene Therapeutics, Inc. and Tactile Systems Technology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALLO
Allogene Therapeutics, Inc.
$1.46HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TCMD
Tactile Systems Technology, Inc.
$22.19HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ALLO vs TCMD
growth of $100 · dividends reinvested · last 8yALLO -94.0% (-29.6%/yr)TCMD -63.0% (-11.7%/yr)TCMD compounded faster over this window
Log scale — wide-divergence pair
ALLO TCMD
ALLO vs TCMD: by the numbers
- •ALLO is the larger company ($504M vs $501M market cap).
- •TCMD is profitable (7.10% net margin) while ALLO runs a net loss (-3566.68%).
- •TCMD grew revenue faster over the past five years (11.62% vs -34.47% CAGR).
Metrics side by side
Valuation
| Metric | ALLO | TCMD |
|---|---|---|
| P/E ratio | N/A | 20.55 |
| Forward P/E | N/A | 19.87 |
| P/S ratio | 108.60 | 1.43 |
| P/B ratio | 1.16 | 2.24 |
| EV / EBITDA | N/A | 10.66 |
| FCF yield | N/A | 5.34% |
Profitability
| Metric | ALLO | TCMD |
|---|---|---|
| Gross margin | 0.00% | 74.23% |
| Operating margin | 0.00% | 10.00% |
| Net margin | -3566.68% | 7.10% |
| ROE | -37.94% | 11.11% |
| ROIC | -34.79% | 9.54% |
Growth (annualized)
| Metric | ALLO | TCMD |
|---|---|---|
| Revenue CAGR (5Y) | -34.47% | 11.62% |
| FCF CAGR (5Y) | N/A | 32.09% |
| Total return CAGR (5Y) | -42.72% | -11.73% |
Frequently asked
- Which has grown faster, ALLO or TCMD?
- Over the past five years, TCMD grew revenue faster — ALLO at a -34.47% CAGR versus TCMD at 11.62%.
- Is ALLO or TCMD more profitable?
- TCMD runs the higher net margin — ALLO at -3566.68% versus TCMD at 7.10%.
- How have ALLO and TCMD total returns compared?
- Over the past 5 years, ALLO delivered -42.72% and TCMD delivered -11.73% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Tactile Systems Technology P/E ratioAllogene Therapeutics ROETactile Systems Technology ROEAllogene Therapeutics operating marginTactile Systems Technology operating marginAllogene Therapeutics revenue growthTactile Systems Technology revenue growthAllogene Therapeutics free cash flowTactile Systems Technology free cash flow
Allogene Therapeutics & Tactile Systems Technology appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.